• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form RW filed by SS Innovations International Inc.

    4/20/26 5:00:02 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care
    Get the next $SSII alert in real time by email
    RW 1 ea0285120-rw_ssinnova.htm WITHDRAWAL REQUEST

     

    April 20, 2026

     

    VIA EDGAR

     

    United States Securities and Exchange Commission

    Division of Corporation Finance

    Office of Industrial Applications & Services

    100 F Street, N.E.

    Washington, D.C. 20549

     

    Re: SS Innovations International, Inc.
      Registration Statement on Form S-1
      File No. 333-293114

     

    Ladies and Gentlemen:

     

    SS Innovations International, Inc. (the “Company”), hereby requests, pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), that the Company’s Registration Statement on Form S-1 (File No. 333-293114), filed with the Securities and Exchange Commission (“SEC”) on February 2, 2026, together with all exhibits thereto (the “Registration Statement”), be withdrawn effective immediately.

     

    The Company has determined not to pursue, at this time, the public offering to which the Registration Statement relates. The Registration Statement has not been declared effective by the SEC, and no securities have been issued or sold under the Registration Statement. Accordingly, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477.

     

    The Company requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the SEC in connection with the filing of the Registration Statement be credited for future use.

     

    It is the Company’s understanding pursuant to Rule 477(b) under the Securities Act, that this request will be deemed granted as of the date that it is filed with the SEC unless, within fifteen (15) days after such date, the Company receives notice from the SEC that this request will not be granted.

     

    Please call our counsel, Dale Bergman of Lewis Brisbois Bisgaard & Smith LLP, at (954) 302-4162 with any questions.

     

    Sincerely,  
       
    SS INNOVATIONS INTERNATIONAL, INC.  
         
    By: /s/ Sudhir Prem Srivastava   
      Sudhir Prem Srivistava, M.D.  
      Chairman and Chief Executive Officer  

     

     

    Get the next $SSII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SSII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SSII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sudhir Srivastava

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    4/15/26 4:16:03 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cohen Barry F

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    4/6/26 5:38:13 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cohen Barry F

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    4/3/26 8:15:56 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026

    FORT LAUDERDALE, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company is hosting the Global Multi-Specialty Robotic Surgery Conference ("SMRSC 2026") in New Delhi, India from April 9-11, 2026. In this third installment of the event, SMRSC 2026 will bring together distinguished surgeons, global thought leaders and prominent innovators to discuss and shape the future of robotic and minimally invasive surgery. Attendance at SMRSC 2026 is expected

    4/7/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya

    FORT LAUDERDALE, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company has received regulatory approval for the SSi Mantra surgical robotic system (the "SSi Mantra"), for multiple indications in Colombia, Oman, Sri Lanka and Kenya. The Company received regulatory approval for the SSi Mantra from the Instituto Nacional de Vigilancia de Medicamentos y Alimentos ("INVIMA") in Colombia in November 2025, from the Directorate General of Pharmaceutical

    3/30/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines

    FORT LAUDERDALE, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines. The Company today also announced that more than 150 cumulative telesurgeries have been successfully performed utilizing the SSi Mantra surgical robotic system, primarily in India. Among recent highlights showcasing the advanced capabilities of the SSi Mantra, a total of

    3/18/26 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Adams Timothy P. bought $1,197,000 worth of shares (300,000 units at $3.99) (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:04:41 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Director Moll Frederic H bought $1,999,999 worth of shares (501,253 units at $3.99), increasing direct ownership by 5% to 10,775,485 units (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    3/10/26 6:05:34 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Amendment: COO - Americas Cohen Barry F bought $3,799 worth of shares (426 units at $8.92), increasing direct ownership by 0.00% to 8,866,888 units (SEC Form 4)

    4/A - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 6:55:24 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    SEC Filings

    View All

    SEC Form RW filed by SS Innovations International Inc.

    RW - SS Innovations International, Inc. (0001676163) (Filer)

    4/20/26 5:00:02 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    4/7/26 8:35:08 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form 10-K/A filed by SS Innovations International Inc.

    10-K/A - SS Innovations International, Inc. (0001676163) (Filer)

    3/31/26 9:10:41 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Leadership Updates

    Live Leadership Updates

    View All

    SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

    FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Milan Rao as the Company's Global Chief Operating Officer and Chief Financial Officer. The Global Chief Operating Officer role is a newly created position. Mr. Rao will succeed Naveen Kumar Amar as Chief Financial Officer following Mr. Amar's resignation from the Company for personal reasons. Mr. Rao will be based in the United States and will work closely with the Chairman a

    1/8/26 5:00:00 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Chief Financial Officer Transition

    FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition. Anup Sethi, SS Innovations' departing CFO, will remain available to advise the Company prior to the appointment of a permanent CFO.   SS Innovations has commenced a search process to identify and recruit a permanent successor for the CFO role

    5/2/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care